BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27054116)

  • 1. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
    Poursani EM; Mohammad Soltani B; Mowla SJ
    Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
    Poursani EM; Mehravar M; Soltani BM; Mowla SJ
    Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.
    Jez M; Ambady S; Kashpur O; Grella A; Malcuit C; Vilner L; Rozman P; Dominko T
    PLoS One; 2014; 9(2):e89546. PubMed ID: 24586860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and differential expression patterns of porcine OCT4 variants.
    Hwang JY; Oh JN; Lee DK; Choi KH; Park CH; Lee CK
    Reproduction; 2015 Jan; 149(1):55-66. PubMed ID: 25342174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
    Wezel F; Pearson J; Kirkwood LA; Southgate J
    Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
    Xu G; Yang L; Zhang W; Wei X
    Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
    Mehravar M; Poursani EM
    Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
    Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
    J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Splicing Generates Different 5' UTRs in OCT4B Variants.
    Poursani EM; Mehravar M; Shahryari A; Mowla SJ; Mohammad Soltani B
    Avicenna J Med Biotechnol; 2017; 9(4):201-204. PubMed ID: 29090070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
    Saha SK; Jeong Y; Cho S; Cho SG
    Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.
    Wang X; Dai J
    Stem Cells; 2010 May; 28(5):885-93. PubMed ID: 20333750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel spliced variants of OCT4, OCT4C and OCT4C1, with distinct expression patterns and functions in pluripotent and tumor cell lines.
    Malakootian M; Mirzadeh Azad F; Naeli P; Pakzad M; Fouani Y; Taheri Bajgan E; Baharvand H; Mowla SJ
    Eur J Cell Biol; 2017 Jun; 96(4):347-355. PubMed ID: 28476334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel alternative splicing variants of Oct4 gene expressed in mouse pluripotent stem cells.
    Liu X; Yu T; Sun Y; Wang H
    J Cell Physiol; 2018 Jul; 233(7):5468-5477. PubMed ID: 29266259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Variant of
    Poursani EM; Mehravar M; Mohammad Soltani B; Mowla SJ; Trosko JE
    Avicenna J Med Biotechnol; 2017; 9(3):142-145. PubMed ID: 28706610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oct4 pseudogenes are transcribed in cancers.
    Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.
    Redshaw Z; Strain AJ
    J Negat Results Biomed; 2010 Mar; 9(1):2. PubMed ID: 20356403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency.
    Tsai SC; Chang DF; Hong CM; Xia P; Senadheera D; Trump L; Mishra S; Lutzko C
    Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1108-18. PubMed ID: 24627557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCT4B modulates OCT4A expression as ceRNA in tumor cells.
    Li D; Yang ZK; Bu JY; Xu CY; Sun H; Tang JB; Lin P; Cheng W; Huang N; Cui RJ; Yu XG; Zheng XL
    Oncol Rep; 2015 May; 33(5):2622-30. PubMed ID: 25812694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
    Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
    BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.
    Mehravar M; Ghaemimanesh F; Poursani EM
    Stem Cell Rev Rep; 2021 Aug; 17(4):1121-1136. PubMed ID: 33389631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.